Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Leuprolide and Flutamide in High-Risk Prostate Cancer Post-Surgery
NCT00003645Phase 3Terminated
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Jun 1999
- Primary completion
- Mar 2017
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of leuprolide, flutamide in prostate cancer (PCa), sponsored by University of Texas MD Anderson Cancer Center. Started Jun 1999; status: terminated.
02
Drugs
leuprolideflutamide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00003645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003645.